Abstract:Background: Asymmetric dimethylarginine (ADMA) has been associated with an increased risk of cardiovascular disease. We investigated the role of serum ADMA concentrations in early-onset coronary artery disease (EOCAD).Methods: Candidates for coronary artery angiography (age < 50 y for men and <55 y for women) who met the inclusion criteria were enrolled in this study. Serum concentrations of ADMA were determined using ELISA. Severity of coronary atherosclerosis was estimated by number of diseased vessels.Results: A total of 601 subjects (286 with EOCAD patients and 315 controls) were included in the study. ADMA concentrations were found to be significantly higher in the EOCAD group (0.480 +/- 0.110 mu mol/1) than in the control group (0.457 +/- 0.091, P = 0.007). ADMA concentrations significantly increased with the number of diseased vessels (P < 0.001). In addition, serum ADMA concentrations were affected by diabetes mellitus and smoking status, and were positively correlated with serum creatinine and body mass index (BMI).Conclusions: Our results show that serum ADMA concentrations were associated with the presence and severity of EOCAD, suggesting that ADMA may be involved in the progression of EOCAD. (C) 2016 Published by Elsevier B.V.

Increased Serum Concentrations of Asymmetric Dimethylarginine (ADMA) in Patients with Early-Onset Coronary Artery Disease.